Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

The International Hypoglycaemia Study Group

doi:10.1007/s00125-016-4146-6

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

The International Hypoglycaemia Study Group

Research output: Contribution to journal › Article › Other › peer-review

Original language	English
Pages (from-to)	3-6
Number of pages	4
Journal	Diabetologia
Volume	60
Issue number	1
DOIs	https://doi.org/10.1007/s00125-016-4146-6
Publication status	Published - 1 Jan 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00125-016-4146-6

106659387-oaFinal published version, 310 KB

Cite this

@article{3508e62721984cd2a95e737ce087c3c2,

title = "Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes",

author = "Amiel, {Stephanie A.} and Pablo Aschner and {Childs R N}, Belinda and Cryer, {Philip E.} and {de Galan}, {Bastiaan E} and Heller, {Simon R.} and Frier, {Brian M.} and Linda Gonder-Frederick and Jones, {Timothy W} and Jones, {Timothy W} and Kamlesh Khunti and Leiter, {Lawrence A} and McCrimmon, {Rory J.} and Yingying Luo and Seaquist, {Elizabeth R.} and Robert Vigersky and Robert Vigersky and Sophia Zoungas and {The International Hypoglycaemia Study Group}",

year = "2017",

month = jan,

day = "1",

doi = "10.1007/s00125-016-4146-6",

language = "English",

volume = "60",

pages = "3--6",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer-Verlag London Ltd.",

number = "1",

}

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes. / The International Hypoglycaemia Study Group.
In: Diabetologia, Vol. 60, No. 1, 01.01.2017, p. 3-6.

Research output: Contribution to journal › Article › Other › peer-review

TY - JOUR

T1 - Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials

T2 - a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

AU - Amiel, Stephanie A.

AU - Aschner, Pablo

AU - Childs R N, Belinda

AU - Cryer, Philip E.

AU - de Galan, Bastiaan E

AU - Heller, Simon R.

AU - Frier, Brian M.

AU - Gonder-Frederick, Linda

AU - Jones, Timothy W

AU - Khunti, Kamlesh

AU - Leiter, Lawrence A

AU - McCrimmon, Rory J.

AU - Luo, Yingying

AU - Seaquist, Elizabeth R.

AU - Vigersky, Robert

AU - Zoungas, Sophia

AU - The International Hypoglycaemia Study Group

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=84996598780&partnerID=8YFLogxK

U2 - 10.1007/s00125-016-4146-6

DO - 10.1007/s00125-016-4146-6

M3 - Article

AN - SCOPUS:84996598780

SN - 0012-186X

VL - 60

SP - 3

EP - 6

JO - Diabetologia

JF - Diabetologia

IS - 1

ER -

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

UN SDGs

Access to Document

Other files and links

Cite this